High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma.

Louis-Brennetot, Caroline; Delattre, Olivier; Janoueix-Lerosey, Isabelle

Louis-Brennetot, Caroline; Delattre, Olivier; Janoueix-Lerosey, Isabelle.

Affiliation

Louis-Brennetot C; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France.
Delattre O; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France.
Janoueix-Lerosey I; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France. Electronic address: janoueix@curie.fr.

EBioMedicine ; 53: 102702, 2020 03.

Article in En | MEDLINE | ID: mdl-32200273

Subject(s)

Neural Crest; Neuroblastoma; Humans; Hyaluronan Receptors; Prognosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neural Crest / Neuroblastoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: EBioMedicine Year: 2020 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google